Several lines of evidence have recently bolstered the belief that by understanding and treating the damage that accumulates in our bodies as we age, we will be able to slow or repair this damage with dramatic benefits for our health and lifespan.
The most studied lines of evidence for this claim are focused on the fields of senescence, genetic manipulation, heterochronic parabiosis, caloric restriction, and even the use of existing drugs like Metformin. We can reproducibly use such techniques to significantly increase the lifespan of animals while delaying the onset of multiple diseases — and this evidence has been built up by world-class scientists at UCSF, Stanford, and more of the world's best labs.
We've built a machine learning platform to accelerate experimentation for discovering therapies for aging and its related diseases.
While the science of aging research is full of promising results, it still takes far too long to run experiments. This significantly slows down the search for therapies that could one day reduce cardiovascular disease, neurodegenerative diseases, arthritis, and more.
Spring Discovery's machine learning-based experimentation platform solves this. We're applying a novel computational approach to one of the most important problems in the world: battling aging and disease.
Founding engineer and VP Engineering at Khan Academy. Early engineer and VP Engineering at Fog Creek Software.
Director of Cell Biology at BioRestorative Therapies. Postdoc at Berkeley focused on skeletal muscle aging. Ph.D. from University Nice Sophia Antipolis.
Product Team Leader at Turing Pharma. Postdoc at Dr. Conboy's lab in Berkeley working on aging. Ph.D. from University Nice Sophia Antipolis.
Senior engineer and technical lead at Khan Academy. Senior engineer at Google.
Member of rescue team that helped fix healthcare.gov.
Senior engineer and technical lead at Khan Academy.
Engineering lead and member of the early team at Cedar, a healthcare technology startup.
Senior data scientist, engineer, and manager at Khan Academy and Chan Zuckerberg Initiative. Ph.D. in Physics and Pop. Genetics at Harvard.
Head of Ops at Age1. PhD in developmental and stem cell biology, UCSF. Stem cell specialist in Dr. Susan Fisher's lab.
Cofounder of Color Genomics and Mixer Labs. Serial angel and entrepreneur.
Head of Chang Lab and Professor of Dermatology at Stanford. Scientific cofounder of Epinomics.
Head of Villeda Lab for aging research at UCSF. PhD from Stanford with focus on reversing aging in the brain.
Senior Vice President of Research, Head of Neuroscience Discovery at Amgen. President/CSO A2 Biotherapeutics.
Vice President, Arcus Bio. Previously Executive Director and head of first automated screening lab at Amgen.
President of Y Combinator.
Co-chair of OpenAI.